RIGL

NASDAQ · Equity

Rigel Pharmaceuticals Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
30.490000
Fair value
20.307218
Expectation
Undecided 48.57%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
30.49
12-Week Change
17.50%
Trend Signal
Inactive
Expectation
Undecided 48.57%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-22.27
Market Dynamics
-0.09

Over the latest 12 completed weeks ending 2026-05-29, RIGL rose 17.50%, moving from 25.95 to 30.49. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -22.27 and has softened across the 12-week window. Market Dynamics is -0.09 on the latest week. Expectation is undecided at 48.57%.